FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021880044> ?p ?o ?g. }

• W2021880044 abstract "Citation of original article: van der Hout AH, et al . A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2 : application in a Dutch cancer clinic setting. Human Mutat 2006; 27 (7): 654–666. Abstract of the original article: Rapid and reliable identification of deleterious changes in the breast cancer genes BRCA1 and BRCA2 has become one of the major issues in most DNA services laboratories. To rapidly detect all possible changes within the coding and splice site determining sequences of the breast cancer genes, we established a semiautomated denaturing gradient gel electrophoresis (DGGE) mutation scanning system. All exons of both genes are covered by the DGGE scan, comprising 120 amplicons. We use a semiautomated approach, amplifying all individual amplicons with the same PCR program, after which the amplicons are pooled. DGGE is performed using three slightly different gel conditions. Validation was performed using DNA samples with known sequence variants in 107 of the 120 amplicons; all variants were detected. This DGGE mutation scanning, in combination with a PCR test for two Dutch founder deletions in BRCA1 was then applied in 431 families in which 52 deleterious changes and 70 unclassified variants were found. Fifteen unclassified variants were not reported before. The system was easily adopted by five other laboratories, where in another 3593 families both exons 11 were analysed by the protein truncation test (PTT ) and the remaining exons by DGGE. In total, a deleterious change (nonsense, frameshift, splice-site mutation or large deletion) was found in 661 families (16.4%), 462 in BRCA1 (11.5%), 197 in BRCA2 (4.9%), and in two index cases a deleterious change in both BRCA1 and BRCA2 was identified. Eleven deleterious changes in BRCA1 and 36 in BRCA2 had not been reported before. In conclusion, this DGGE mutation screening method for BRCA1 and BRCA2 is proven to be highly sensitive and is easy to adopt, which makes screening of large numbers of patients feasible. The results of screening of BRCA1 and BRCA2 in more than 4000 families present a valuable overview of mutations in the Dutch population." @default.
• W2021880044 created "2016-06-24" @default.
• W2021880044 creator A5013817463 @default.
• W2021880044 date "2007-02-01" @default.
• W2021880044 modified "2023-10-18" @default.
• W2021880044 title "Review of: A DGGE system for comprehensive mutation screening ofBRCA1andBRCA2: application in a Dutch cancer clinic setting" @default.
• W2021880044 cites W1993364189 @default.
• W2021880044 cites W2005682952 @default.
• W2021880044 cites W2010200226 @default.
• W2021880044 cites W2019983958 @default.
• W2021880044 cites W2034428861 @default.
• W2021880044 cites W2037168479 @default.
• W2021880044 cites W2047012007 @default.
• W2021880044 cites W2054605948 @default.
• W2021880044 cites W2061472576 @default.
• W2021880044 cites W2071937923 @default.
• W2021880044 cites W2087025655 @default.
• W2021880044 cites W2109465247 @default.
• W2021880044 cites W2120059431 @default.
• W2021880044 cites W2125650759 @default.
• W2021880044 cites W2136236200 @default.
• W2021880044 cites W2140370011 @default.
• W2021880044 cites W38965776 @default.
• W2021880044 doi "https://doi.org/10.1017/s1470903107005743" @default.
• W2021880044 hasPublicationYear "2007" @default.
• W2021880044 type Work @default.
• W2021880044 sameAs 2021880044 @default.
• W2021880044 citedByCount "1" @default.
• W2021880044 crossrefType "journal-article" @default.
• W2021880044 hasAuthorship W2021880044A5013817463 @default.
• W2021880044 hasBestOaLocation W20218800441 @default.
• W2021880044 hasConcept C104317684 @default.
• W2021880044 hasConcept C121608353 @default.
• W2021880044 hasConcept C198549448 @default.
• W2021880044 hasConcept C2780989783 @default.
• W2021880044 hasConcept C29906990 @default.
• W2021880044 hasConcept C36823959 @default.
• W2021880044 hasConcept C42062724 @default.
• W2021880044 hasConcept C49105822 @default.
• W2021880044 hasConcept C501734568 @default.
• W2021880044 hasConcept C54355233 @default.
• W2021880044 hasConcept C75563809 @default.
• W2021880044 hasConcept C8185291 @default.
• W2021880044 hasConcept C86803240 @default.
• W2021880044 hasConcept C96777560 @default.
• W2021880044 hasConceptScore W2021880044C104317684 @default.
• W2021880044 hasConceptScore W2021880044C121608353 @default.
• W2021880044 hasConceptScore W2021880044C198549448 @default.
• W2021880044 hasConceptScore W2021880044C2780989783 @default.
• W2021880044 hasConceptScore W2021880044C29906990 @default.
• W2021880044 hasConceptScore W2021880044C36823959 @default.
• W2021880044 hasConceptScore W2021880044C42062724 @default.
• W2021880044 hasConceptScore W2021880044C49105822 @default.
• W2021880044 hasConceptScore W2021880044C501734568 @default.
• W2021880044 hasConceptScore W2021880044C54355233 @default.
• W2021880044 hasConceptScore W2021880044C75563809 @default.
• W2021880044 hasConceptScore W2021880044C8185291 @default.
• W2021880044 hasConceptScore W2021880044C86803240 @default.
• W2021880044 hasConceptScore W2021880044C96777560 @default.
• W2021880044 hasLocation W20218800441 @default.
• W2021880044 hasOpenAccess W2021880044 @default.
• W2021880044 hasPrimaryLocation W20218800441 @default.
• W2021880044 hasRelatedWork W1494643260 @default.
• W2021880044 hasRelatedWork W179064230 @default.
• W2021880044 hasRelatedWork W1967434184 @default.
• W2021880044 hasRelatedWork W1971086537 @default.
• W2021880044 hasRelatedWork W2072126255 @default.
• W2021880044 hasRelatedWork W2075503019 @default.
• W2021880044 hasRelatedWork W2146433281 @default.
• W2021880044 hasRelatedWork W2329070144 @default.
• W2021880044 hasRelatedWork W2352043710 @default.
• W2021880044 hasRelatedWork W2594801 @default.
• W2021880044 isParatext "false" @default.
• W2021880044 isRetracted "false" @default.
• W2021880044 magId "2021880044" @default.
• W2021880044 workType "article" @default.